These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 22530898)
1. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives. Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors. Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618 [TBL] [Abstract][Full Text] [Related]
3. Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies. Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Ali M; Abdullah N; Khan KM Bioorg Med Chem; 2015 Jul; 23(13):3119-25. PubMed ID: 26001340 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies. Khan KM; Rahim F; Wadood A; Taha M; Khan M; Naureen S; Ambreen N; Hussain S; Perveen S; Choudhary MI Bioorg Med Chem Lett; 2014 Apr; 24(7):1825-9. PubMed ID: 24602903 [TBL] [Abstract][Full Text] [Related]
5. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors. Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines. Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. Khan KM; Saad SM; Shaikh NN; Hussain S; Fakhri MI; Perveen S; Taha M; Choudhary MI Bioorg Med Chem; 2014 Jul; 22(13):3449-54. PubMed ID: 24844756 [TBL] [Abstract][Full Text] [Related]
8. Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives. Salar U; Khan KM; Taha M; Ismail NH; Ali B; Qurat-Ul-Ain ; Perveen S; Ghufran M; Wadood A Eur J Med Chem; 2017 Jan; 125():1289-1299. PubMed ID: 27886546 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies. Taha M; Ullah H; Al Muqarrabun LMR; Khan MN; Rahim F; Ahmat N; Ali M; Perveen S Eur J Med Chem; 2018 Jan; 143():1757-1767. PubMed ID: 29133042 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors. Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943 [TBL] [Abstract][Full Text] [Related]
11. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors. Menteşe E; Emirik M; Sökmen BB Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848 [TBL] [Abstract][Full Text] [Related]
13. 2,5-Disubstituted thiadiazoles as potent β-glucuronidase inhibitors; Synthesis, in vitro and in silico studies. Taha M; Barak Almandil N; Rashid U; Ali M; Ibrahim M; Gollapalli M; Mosaddik A; Mohammed Khan K Bioorg Chem; 2019 Oct; 91():103126. PubMed ID: 31349116 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease. Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors. Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues. Zaman K; Rahim F; Taha M; Ullah H; Wadood A; Nawaz M; Khan F; Wahab Z; Shah SAA; Rehman AU; Kawde AN; Gollapalli M Bioorg Chem; 2019 Aug; 89():103024. PubMed ID: 31176853 [TBL] [Abstract][Full Text] [Related]
17. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes. Arshad T; Khan KM; Rasool N; Salar U; Hussain S; Asghar H; Ashraf M; Wadood A; Riaz M; Perveen S; Taha M; Ismail NH Bioorg Chem; 2017 Jun; 72():21-31. PubMed ID: 28346872 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles. Salar U; Khan KM; Syed S; Taha M; Ali F; Ismail NH; Perveen S; Wadood A; Ghufran M Bioorg Chem; 2017 Feb; 70():199-209. PubMed ID: 28069264 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking. Khan KM; Rahim F; Halim SA; Taha M; Khan M; Perveen S; Zaheer-Ul-Haq ; Mesaik MA; Iqbal Choudhary M Bioorg Med Chem; 2011 Jul; 19(14):4286-94. PubMed ID: 21684753 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of (thio)urea derivatives as potent Xu K; Ying L; Ying T; Wu Q; Du L; Yu Y; Ying Y; Wei B; Wang H; Yang Z J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2387415. PubMed ID: 39140677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]